A new trading day began on Friday, with Oncology Institute Inc (NASDAQ: TOI) stock price down -0.65% from the previous day of trading, before settling in for the closing price of $0.16. TOI’s price has ranged from $0.13 to $2.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 15.26% over the past five years. With a float of $37.08 million, this company’s outstanding shares have now reached $74.15 million.
Let’s look at the performance matrix of the company that is accounted for 800 employees. In terms of profitability, gross margin is 13.37%, operating margin of -16.75%, and the pretax margin is -18.56%.
Oncology Institute Inc (TOI) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Care Facilities Industry. The insider ownership of Oncology Institute Inc is 50.93%, while institutional ownership is 22.59%. The most recent insider transaction that took place on Jan 29 ’24, was worth 18,310. In this transaction 10% Owner of this company sold 8,637 shares at a rate of $2.12, taking the stock ownership to the 0 shares. Before that another transaction happened on Jan 24 ’24, when Company’s 10% Owner sold 24,915 for $2.30, making the entire transaction worth $57,304. This insider now owns 27,498 shares in total.
Oncology Institute Inc (TOI) Latest Financial update
In its latest quarterly report, released on 6/30/2024, the company reported earnings of 0.05 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Oncology Institute Inc (NASDAQ: TOI) Trading Performance Indicators
Here are Oncology Institute Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.27. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.77
Technical Analysis of Oncology Institute Inc (TOI)
Oncology Institute Inc (NASDAQ: TOI) saw its 5-day average volume 8.86 million, a positive change from its year-to-date volume of 0.35 million. As of the previous 9 days, the stock’s Stochastic %D was 11.96%. Additionally, its Average True Range was 0.04.
During the past 100 days, Oncology Institute Inc’s (TOI) raw stochastic average was set at 6.05%, which indicates a significant decrease from 14.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 197.78% in the past 14 days, which was higher than the 116.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2905, while its 200-day Moving Average is $0.7544. Nevertheless, the first resistance level for the watch stands at $0.1662 in the near term. At $0.1783, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.1887. If the price goes on to break the first support level at $0.1437, it is likely to go to the next support level at $0.1333. The third support level lies at $0.1212 if the price breaches the second support level.
Oncology Institute Inc (NASDAQ: TOI) Key Stats
With a market capitalization of 11.56 million, the company has a total of 75,559K Shares Outstanding. Currently, annual sales are 324,240 K while annual income is -83,070 K. The company’s previous quarter sales were 99,900 K while its latest quarter income was -16,110 K.
